Ameriprise Financial Inc. cut its stake in Aetna Inc. (NYSE:AET) by 2.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,387,592 shares of the company’s stock after selling 63,116 shares during the period. Ameriprise Financial Inc. owned approximately 0.73% of Aetna worth $379,805,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State of Tennessee Treasury Department boosted its position in shares of Aetna by 26.3% in the second quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after acquiring an additional 116,280 shares during the last quarter. Banque Pictet & Cie SA purchased a new position in Aetna in the second quarter valued at approximately $10,567,000. Pictet & Cie Europe SA purchased a new position in Aetna in the second quarter valued at approximately $2,269,000. NBT Bank N A NY purchased a new position in Aetna in the second quarter valued at approximately $215,000. Finally, Eaton Vance Management raised its holdings in Aetna by 18.3% in the second quarter. Eaton Vance Management now owns 1,050,685 shares of the company’s stock valued at $159,526,000 after buying an additional 162,502 shares during the period. 88.41% of the stock is currently owned by institutional investors and hedge funds.

Shares of Aetna Inc. (NYSE AET) opened at $176.30 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. Aetna Inc. has a 1 year low of $116.04 and a 1 year high of $184.98. The company has a market cap of $57,047.94, a PE ratio of 17.13, a price-to-earnings-growth ratio of 1.59 and a beta of 0.61.

Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same period in the previous year, the business earned $2.07 earnings per share. Aetna’s revenue for the quarter was down 5.0% compared to the same quarter last year. equities analysts anticipate that Aetna Inc. will post 9.78 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were issued a dividend of $0.50 per share. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 annualized dividend and a yield of 1.13%. Aetna’s payout ratio is presently 37.04%.

In other Aetna news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Aetna Inc. (AET) Shares Sold by Ameriprise Financial Inc.” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/aetna-inc-aet-shares-sold-by-ameriprise-financial-inc/1719728.html.

Several research firms recently commented on AET. Piper Jaffray Companies restated a “hold” rating and issued a $187.00 price target on shares of Aetna in a report on Friday, November 3rd. Raymond James Financial, Inc. upgraded shares of Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price target on the stock in a report on Friday, November 3rd. Credit Suisse Group began coverage on shares of Aetna in a report on Thursday, November 2nd. They issued a “neutral” rating and a $174.00 price target on the stock. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Finally, Citigroup Inc. lifted their price objective on shares of Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research note on Thursday, November 2nd. Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Aetna currently has a consensus rating of “Buy” and an average target price of $172.36.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.